OCT Clinical Unveils OCT Oncology™ Solution Package
OCT Clinical has announced the extension of its services via its OCT Oncology™ solution, to address needs in oncology clinical research, with a special focus on emerging biotechs.
To accomodate the specialized attention emerging oncology therapies often require, OCT Clinical focuses on accelerated access, speedy enrollment, and ultimately cost efficiency.
This is achievied with the help of digital solutions that emerging companies can benefit from:
- CTMS with real-time data access and data hub for risk management
- EDC roll-out tailored to early phase oncology (error-checking during data entry at sites allows for early detection and correction of errors to avoid additional costs associated with the double entry of data from paper-based forms)
- eCRF templates that also help to save time and resources
Read more about the new solution package here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
